Literature DB >> 1496017

Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations.

A Wedell1, E M Ritzén, B Haglund-Stengler, H Luthman.   

Abstract

Lesions in the gene encoding steroid 21-hydroxylase [steroid hydrogen-donor: oxygen oxidoreductase (21-hydroxylating), EC 1.14.99.10] result in defective adrenal steroid synthesis; the severe forms are known as congenital adrenal hyperplasia. To facilitate complete characterization of mutations in this region of tandemly repeated genes, we have developed selective PCR amplification and direct sequencing of full-length nonpseudogene steroid 21-hydroxylase genes. This technique identifies known mutations, characterizes or excludes unknown mutations, and determines the gene-copy number. Three additional defective alleles were found. A Gly-292----Ser mutation and a frameshift mutation at Arg-484 (GG----C) were identified in patients with severe steroid 21-hydroxylase deficiency. An allele with three additional sequence variations--C----T at 4 bases upstream of translation initiation, Pro-106----Leu, and Pro-454----Ser--were identified in two siblings with late-onset deficiency. Pro-454 is conserved in four species, indicating its importance for normal enzyme function. Functional consequences of individual alleles have been determined in vivo by studying individuals with only one steroid 21-hydroxylase gene. Detailed analyses of clinical data revealed that genotyping could predict the clinical course of the disease. The locations of disease-causing mutations on different haplotypes of the steroid 21-hydroxylase gene region are described.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496017      PMCID: PMC49680          DOI: 10.1073/pnas.89.15.7232

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support.

Authors:  T Hultman; S Ståhl; E Hornes; M Uhlén
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

2.  A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele.

Authors:  M T Tusie-Luna; P W Speiser; M Dumic; M I New; P C White
Journal:  Mol Endocrinol       Date:  1991-05

3.  Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency.

Authors:  E Mornet; P Crété; F Kuttenn; M C Raux-Demay; J Boué; P C White; A Boué
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

4.  21-hydroxylase deficiency: disease-causing mutations categorized by densitometry of 21-hydroxylase-specific deoxyribonucleic acid fragments.

Authors:  B Haglund-Stengler; E M Ritzén; H Luthman
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

5.  Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification.

Authors:  D Owerbach; Y M Crawford; M B Draznin
Journal:  Mol Endocrinol       Date:  1990-01

6.  Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus.

Authors:  M T Tusie-Luna; P Traktman; P C White
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

7.  Multiple regulatory elements determine adrenocortical expression of steroid 21-hydroxylase.

Authors:  D A Rice; M S Kronenberg; A R Mouw; L D Aitken; A Franklin; B P Schimmer; K L Parker
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

8.  Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively.

Authors:  D A Wu; B C Chung
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  A missense mutation at Ile172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency.

Authors:  S H Chiou; M C Hu; B C Chung
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  29 in total

1.  Characterisation of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene.

Authors:  A Bobba; A Iolascon; S Giannattasio; M Albrizio; A Sinisi; F Prisco; F Schettini; E Marra
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

2.  Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Gabriela P Finkielstain; Wuyan Chen; Sneha P Mehta; Frank K Fujimura; Reem M Hanna; Carol Van Ryzin; Nazli B McDonnell; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2010-10-06       Impact factor: 5.958

3.  Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia.

Authors:  Tiina Robins; Christine Bellanne-Chantelot; Michela Barbaro; Sylvie Cabrol; Anna Wedell; Svetlana Lajic
Journal:  J Mol Med (Berl)       Date:  2006-11-21       Impact factor: 4.599

4.  Identification and functional characterization of a novel mutation P459H and a rare mutation R483W in the CYP21A2 gene in two Chinese patients with simple virilizing form of congenital adrenal hyperplasia.

Authors:  L Jiang; L L Song; H Wang; J L Wang; P P Wang; H B Zhou; X L Zhang
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

5.  Functional studies of two novel and two rare mutations in the 21-hydroxylase gene.

Authors:  M Barbaro; L Baldazzi; A Balsamo; S Lajic; T Robins; L Barp; P Pirazzoli; E Cacciari; A Cicognani; A Wedell
Journal:  J Mol Med (Berl)       Date:  2006-03-16       Impact factor: 4.599

Review 6.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

7.  Detection of a novel severe mutation affecting the CYP21A2 gene in a Chilean male with salt wasting congenital adrenal hyperplasia.

Authors:  Eugenio Arteaga; Felipe Valenzuela; Carlos F Lagos; Marcela Lagos; Alejandra Martinez; Rene Baudrand; Cristian Carvajal; Carlos E Fardella
Journal:  Endocrine       Date:  2019-09-30       Impact factor: 3.633

Review 8.  Molecular pathology of 21-hydroxylase deficiency.

Authors:  T Strachan
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency.

Authors:  A Wedell; B Stengler; H Luthman
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

10.  Nonclassic congenital adrenal hyperplasia.

Authors:  Selma Feldman Witchel; Ricardo Azziz
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.